BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22081005)

  • 1. Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis.
    Fogari R; Maffioli P; Mugellini A; Zoppi A; Lazzari P; Derosa G
    Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):164-71. PubMed ID: 22081005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients.
    Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Seo YH; Kang MH; Ahn TH; Choi IS; Shin EK
    Circulation; 2004 Dec; 110(24):3687-92. PubMed ID: 15569835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
    Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
    J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perindopril and barnidipine alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients.
    Derosa G; Mugellini A; Pesce RM; D'Angelo A; Maffioli P
    Eur J Pharmacol; 2015 Nov; 766():31-6. PubMed ID: 26407654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
    Derosa G; Querci F; Franzetti I; Dario Ragonesi P; D'Angelo A; Maffioli P
    Hypertens Res; 2015 Oct; 38(10):690-4. PubMed ID: 25994603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Clin Exp Hypertens; 2013; 35(5):301-7. PubMed ID: 22954201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.
    Maffioli P; Fogari E; D'Angelo A; Perrone T; Derosa G
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1113-22. PubMed ID: 23524525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
    Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients.
    Han SH; Koh KK; Quon MJ; Lee Y; Shin EK
    Atherosclerosis; 2007 Jan; 190(1):205-11. PubMed ID: 16500662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, controlled study of losartan in children with proteinuria.
    Webb NJ; Lam C; Loeys T; Shahinfar S; Strehlau J; Wells TG; Santoro E; Manas D; Gleim GW
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):417-24. PubMed ID: 20089489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of simvastatin on the antihypertensive activity of losartan in hypertensive hypercholesterolemic animals and patients: role of nitric oxide, oxidative stress, and high-sensitivity C-reactive protein.
    Abdel-Zaher AO; Elkoussi AE; Abudahab LH; Elbakry MH; Elsayed EA
    Fundam Clin Pharmacol; 2014 Jun; 28(3):237-48. PubMed ID: 23488690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy.
    Ohta Y; Kawano Y; Iwashima Y; Hayashi S; Yoshihara F; Matayoshi T; Takiuchi S; Kamide K; Nakamura S; Horio T
    Clin Exp Hypertens; 2013; 35(4):279-84. PubMed ID: 23530977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats.
    Choi SM; Seo MJ; Kang KK; Kim JH; Ahn BO; Yoo M
    Arch Pharm Res; 2009 Mar; 32(3):353-8. PubMed ID: 19387578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
    Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
    Peng F; Lin J; Lin L; Tang H
    Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
    Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
    Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension.
    Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Murakami K; Higaki J
    Clin Ther; 2006 Oct; 28(10):1677-85. PubMed ID: 17157123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients.
    Derosa G; Maffioli P; Ferrari I; Palumbo I; Randazzo S; Fogari E; D'Angelo A; Cicero AF
    Hypertens Res; 2011 Jan; 34(1):145-51. PubMed ID: 21107327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.
    Cicero AF; Veronesi M; Prandin MG; Di Gregori V; Ambrosioni E; Borghi C
    Fundam Clin Pharmacol; 2009 Oct; 23(5):583-8. PubMed ID: 19555395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.